Andrea Tan

Stock Analyst at Goldman Sachs

(1.48)
# 3,503
Out of 5,017 analysts
47
Total ratings
40.54%
Success rate
-9.85%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Andrea Tan

Insmed
Oct 3, 2025
Maintains: Buy
Price Target: $121$196
Current: $163.94
Upside: +19.56%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16$8
Current: $2.14
Upside: +273.83%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46$51
Current: $70.34
Upside: -27.50%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39$27
Current: $7.19
Upside: +275.52%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23$6
Current: $7.60
Upside: -21.05%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $36.25
Upside: -14.48%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3$2
Current: $2.02
Upside: -0.99%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $11.60
Upside: -82.76%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $184.74
Upside: -13.39%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27$24
Current: $5.67
Upside: +323.28%
Maintains: Sell
Price Target: $10$4
Current: $1.39
Upside: +187.77%
Maintains: Buy
Price Target: $178$375
Current: $427.73
Upside: -12.33%
Maintains: Neutral
Price Target: $120$80
Current: $32.29
Upside: +147.75%